FDA Announced Children Could Now be Administered Monkeypox Vaccine, to Expand Shots Through Intradermal Injection

Photo Credit: Gilaxia via Getty Images

The U.S. Food and Drug Administration announced on Tuesday that Monkeypox vaccines could now be conducted to a broader age bracket, allowing the country to better deal with the epidemic, which has received the highest threat level by the World Health Organization.

According to the announcement, children who are at high risk of contracting the virus are eligible for the vaccine. Dr. Peter Marks, the FDA’s head of the vaccine division, stated that children had been exposed to Monkeypox in recent weeks.

Adults may receive vaccine shots via intradermal injection, which means the vaccine is administered between the layers of the skin. This new directive has allowed for a fivefold increase in vaccine availability. Previously, Monkeypox vaccines were administered via subcutaneous injection, which requires a higher dosage because it is injected beneath the skin.

According to Robert Fenton, the White House’s Monkeypox response coordinator, intradermal injections require only a small dose of the vaccines. As per assessments and calculations, 400,000 vials of vaccines intended for subcutaneous injection equate to approximately 2 million shots of vaccine conducted via intradermal injection.

However, children would be limited to subcutaneous injections because more research is needed before the FDA and the White House response team authorize intradermal injections for individuals under the age of 18. Children, according to Fenton, are more difficult to treat than adults.

Read Also: UK Faces Hottest Period in Decades, 60% of EU Placed Under Heat Signals, Warnings

Vaccines are imported from Denmark

The only monkeypox immunization that has gotten FDA approval is the Jynneos vaccine, produced by Bavarian Nordic. The biotech company is based in Denmark, and it has been in touch with the U.S. government about the shortage of monkeypox vaccines.

Biden previously worked with Bavarian Nordic to increase the supply of Monkeypox vaccines in the U.S., amid claims from health agencies and hospitals of long waits caused by a lack of Jynneos vials. More vaccine shots are on their way, according to Bavarian Nordic, and more will arrive by next year if the shipment is approved by the FDA.

While this is true, Dr. Robert Calliff, Commissioner of the FDA, stated that experts could not say for certain how well the vaccine protects against the Monkeypox virus because there have been no recent smallpox cases or Monkeypox outbreaks in the country. Bavarian Nordic received the FDA’s go signal in 2019 solely based on immune response data.

Meanwhile, the Centers for Disease Control and Prevention announced that it would conduct research and inferences to assess the vaccine’s efficacy in a real-world setting. The CDC’s Dr. Rochelle Walensky assured that as the vaccine is administered, the research will progress.

Read Also: Billionaires Invest Large Sums to Start Mineral Exploration Under Melting Greenland Ice Sheets

Government is having a hard time dealing with the supply shortage of vaccines

The outbreak has spread across countries, and new cases are being reported on a frequent basis. As time goes on, more people are trying to obtain vaccine shots, and the supply is running low. With only Bavarian Nordic as a supplier of vaccines, the government is having difficulty calming the fears of health professionals and citizens about vaccine supply.

The CDC has long confirmed Monkeypox cases in 49 U.S. states, including Washington, D.C. and Puerto Rico. The Health and Human Services Department recently declared the monkeypox outbreak a public health emergency.

Despite the fact that Monkeypox seldom results in patient fatalities, a lot of patients end up in hospitals because of the painful sores they get. Although there have not yet been any reported fatalities in the U.S., the WHO reports that there have now been 9,000 confirmed cases of Monkeypox.

Monkeypox is primarily transmitted through skin-to-skin contact, particularly during sex. Public health officials also advise citizens to avoid densely populated areas because the virus can be transmitted through close physical contact.

Monkeypox is not gender-specific, according to medical professionals, despite the fact that gay and bisexual men account for about 98% of reported cases. If it is not stopped right away, there is a good chance that the virus will spread to a bigger group.

Source: CNBC

Opinions expressed by US Business News contributors are their own.

Ivan Ryan

Posted by Ivan Ryan

Ivan is a digital marketer with an interest in business. He loves reading self-help books and memoirs of successful people in business.

Leave a Reply

Your email address will not be published.